Asia Pacific has been the fastest growing region in multi-specific monoclonal antibody trials since 2018, with the region contributing to over 40% of the global trials, relatively higher than that of the US and Europe.
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
Singapore – 19 September 2023 - Novotech, the leading Asia Pacific centred biote
Read more